SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-035586
Filing Date
2024-03-18
Accepted
2024-03-18 16:31:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A tm249108d2_defa14a.htm DEFA14A 35989
  Complete submission text file 0001104659-24-035586.txt   37222
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37853 | Film No.: 24759510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)